Simple and rapid determination of nevirapine in human serum by reversed-phase high-performance liquid chromatography

被引:33
作者
Lopez, RM
Pou, L
Gomez, MR
Ruiz, I
Monterde, J
机构
[1] Hosp Gen Univ Vall Dhebron, Dept Pharm, Barcelona 08035, Spain
[2] Hosp Gen Univ Vall Dhebron, Dept Biochem, Barcelona 08035, Spain
[3] Hosp Gen Univ Vall Dhebron, Dept Infect Dis, Barcelona 08035, Spain
来源
JOURNAL OF CHROMATOGRAPHY B | 2001年 / 751卷 / 02期
关键词
nevirapine;
D O I
10.1016/S0378-4347(00)00476-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Nevirapine is an antiretroviral agent belonging to the class of non-nucleoside reverse transcriptase inhibitors. We describe a fast, simple isocratic reversed-phase high-performance liquid chromatography method with a 30-mm long column for assaying nevirapine in human serum. After deproteinization of 200 mul serum samples with 50% trichloroacetic acid, the supernatant was injected into a reversed-phase C-18 column, using 10 mM phosphate buffer (pH 5)-acetonitrile (82:18, v/v) as the mobile phase. Peak detection was performed at 240 nm. Nevirapine retention time was 2 min. The method was validated over 0.1-10 mug/ml and the assay was linear over this concentration range (r(2)>0.998). Within- and between-day precisions were less than 5.4%. The lower limit of quantification was 0.1 mug/ml. Nevirapine in human serum samples was stable for 2 days at 20-25 degreesC, 15 days at 4 degreesC and 3 months at -20 degreesC. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:371 / 376
页数:6
相关论文
共 8 条
[1]   Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection [J].
Barry, M ;
Mulcahy, F ;
Merry, C ;
Gibbons, S ;
Back, D .
CLINICAL PHARMACOKINETICS, 1999, 36 (04) :289-304
[2]   Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection [J].
De Clercq, E .
FARMACO, 1999, 54 (1-2) :26-45
[3]  
De Wit S, 1999, Rev Med Brux, V20, P95
[4]  
JAJARAY A, 1995, PHARMACEUT RES, V9, pS334
[5]   Drug interactions of HIV protease inhibitors [J].
Malaty, LI ;
Kuper, JJ .
DRUG SAFETY, 1999, 20 (02) :147-169
[6]   The pharmacokinetics of combination therapy with nelfinavir plus nevirapine [J].
Merry, C ;
Barry, MG ;
Mulcahy, F ;
Ryan, M ;
Tjia, JF ;
Halifax, KL ;
Breckenridge, AM ;
Back, DJ .
AIDS, 1998, 12 (10) :1163-1167
[7]  
MOYER TP, 1999, CLIN CHEM, V45
[8]   Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection [J].
van Heeswijk, RPG ;
Hoetelmans, RMW ;
Meenhorst, PL ;
Mulder, JW ;
Beijnen, JH .
JOURNAL OF CHROMATOGRAPHY B, 1998, 713 (02) :395-399